“Dementia with Lewy Bodies: Filling the Gaps in Translational and Clinical Research.” This prestigious workshop, sponsored by the NIA and the National Institute of Neurological Disorders and Stroke ...

Nilotinib, a blood cancer medicine, was previously shown to improve movement and mental function in a small group of patients ...

It seems like not a day goes by without billionaire Elon Musk making headlines. The boss of X (formerly Twitter), Tesla and SpaceX is the world's richest person and has used his platform to make ...

"It's well known that sleep disturbances such as REM sleep behavior disorder can be early predictors of conditions including Lewy body dementia or Parkinson's disease, Isaacson said.Monitoring sleep ...

Opens in a new tab or window The chronic myeloid leukemia drug nilotinib (Tasigna) improved biomarkers and cognitive outcomes in people with dementia with Lewy bodies (DLB), a small phase II trial ...

today announced that it will deliver an oral presentation providing detailed safety and efficacy results from its completed RewinD-LB Phase 2b clinical trial of neflamapimod in dementia with Lewy ...

Lewy Body Dementia is a type of dementia caused by the build-up of proteins called Lewy bodies in the brain. These proteins damage parts of the brain responsible for thinking, movement and memory.

Lewy Body Dementia is a type of dementia caused by the build-up of proteins called Lewy bodies in the brain. These proteins damage parts of the brain responsible for thinking, movement and memory. LBD ...

The Penguin recently aired its sixth episode. The episode was filled with interesting twists and turns, leaving viewers on ...

Lewy Body Dementia is a brain disease that mainly targets people above 5o. It’s an incurable disease that doesn’t allow the patient to lead an ordinary life; they won’t be able to do their everyday ...